Following initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
David Schoenbaechler, PharmD
Advertisement
Articles by David Schoenbaechler, PharmD
Advertisement
Latest Updated Articles
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast CancerPublished: July 27th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Cholesterol-HDL-Glucose Index Linked to Type 2 Diabetes Prevalence in Adults
5
